Nistelrode, Netherlands

Jocominus Antonius Maria Zwinkels


 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jocominus Antonius Maria Zwinkels

Introduction

Jocominus Antonius Maria Zwinkels is a notable inventor based in Nistelrode, Netherlands. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on innovative formulations that enhance the efficacy of medications.

Latest Patents

Zwinkels' latest patents include a pharmaceutical formulation comprising losartan potassium and chlorthalidone. This invention is a pharmaceutical tablet formulation that contains between about 12.5 mg and 100 mg of losartan potassium, between about 6.25 mg and about 50 mg of chlorthalidone, and sodium bicarbonate in an amount between about 1.0% and about 10.0% by weight. Another significant patent is for stabilized tibolone compositions, which involve a stabilized pharmaceutical dosage unit comprising tibolone, in an amount of from 0.1% to 10% by weight of the dosage unit, and a pharmaceutically acceptable carrier. This dosage unit is contained in a humid atmosphere of 50 to 70% relative humidity until administration.

Career Highlights

Throughout his career, Zwinkels has worked with prominent companies such as Akzo Nobel N.V. and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Zwinkels has collaborated with notable individuals in his field, including Pieter De Haan and Theodora Antonia Maria Lambregts Vd Hurk. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Jocominus Antonius Maria Zwinkels is a distinguished inventor whose work in pharmaceutical formulations has led to valuable innovations. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…